EDP1503
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EDP1503, covering 2025-12-08 to 2025-12-08. Get the full timeline:
Most recent: Clinical Trial Update: Pembrolizumab and EDP1503 in Advanced Melanoma [Phase 2]